The ARREST-TB Project
The ARREST-TB project aims to develop a suite of technologies to rapidly, accurately and economically detect, report and monitor TB and MDR TB, and monitor response to anti-TB treatments.
Tuberculosis (TB) is the most lethal infectious disease, claiming 1.6 million lives in 2017. Drug-resistant TB cases continue to rise and the World Health Organisation estimates that only 25% of all cases are actually identified.
TB is curable if diagnosed on time and it is estimated that treatment saved the lives of 54million people between 2000 and 2017.
However, several high TB burden countries have poor access to appropriate diagnosis, as most of the current ‘gold standard’ diagnostic tools are expensive and ill adapted to resource-limited settings.
New affordable diagnostic tools are urgently required to improve detection of TB, especially in difficult to diagnose groups, for drug-resistant cases and in settings where lab infrastructure is limited.